Truvada patients may be at high risk of severe health conditions, including kidney and bone injuries. Recent studies found the HIV and PrEP drug’s active ingredient may be extremely toxic for users and cause potentially fatal injuries.
If you took Truvada and experienced kidney or bone injuries, contact AVA Law Group for experienced Truvada lawyers. Time is limited to hold Truvada manufacturers responsible. Call us today to learn if you may be eligible for financial compensation for your suffering.
Truvada is a drug prescribed in addition with other therapies for treating Human Immunodeficiency Virus (HIV). Though it is not a cure for HIV or AIDS, Truvada helps patients lower their risk of developing complications related to HIV.
If left untreated, HIV can develop into Acquired Immunodeficiency Syndrome (AIDS), so drugs like Truvada fulfill a massive need in the marketplace for HIV patients.
The medication can also be used for Pre-Exposure Prophylaxis (PrEP) treatment, or protecting oneself before coming into contact with HIV-1 through sex practices.
Recent studies have found Truvada's active ingredient to be highly toxic and harmful to patients.
Truvada is a mixture of emtricitabine and tenofovir disoproxil fumarate (TDF), an antiviral medicine found in other HIV/PrEP drugs. TDF works in Truvada to decrease HIV levels in the body while aiding the immune system. Other TDF drugs on the market for PrEP and HIV treatment include Atripla, Stribild, Viread, etc.
However, recent lawsuits from across the country claim TDF can cause severe side effects, doing more harm than good. Individuals allege TDF is too toxic and can cause severe injuries like osteoporosis, kidney failure, and lactic acidosis.
Claims state TDF in Truvada can cause the following serious injuries:
Those at risk of developing TDF injuries could include the following:
Gilead Sciences Inc. is the developer of all TDF medications currently on the market and received FDA approval for Truvada in 2004. Truvada sales reach up into the billions of dollars annually and dominates the marketplace for PrEP treatment.
However, allegations state Gilead Sciences knew Truvada’s toxicity was too high and still marketed the drug to public. In fact, many Truvada lawsuits say Gilead knew a safer alternative to Truvada was available and refused to market it.
Gilead released the less toxic option, tenofovir alafenamide fumarate (TAF), years after Truvada and other TDF medications were on the market. Truvada lawsuits allege Gilead knew TDF was more toxic than TAF, and TAF could be given at a lower dose with the same effectiveness as TDF.
Plaintiffs argue Gilead held out on marketing TAF until the patents on their TDF drugs ran out to increase company profits. As of June 2018, Truvada carried a whopping list price of $2,000 for a 30-day supply. While TDF dug patents began expiring last year, TAF drugs have patent protection until 2032. Gilead Sciences shelved TAF in 2004 and did not start selling TAF drugs until over 10 years later in 2015. Because of the delay, TDF drug dependents took a drug too toxic to be safe and developed severe health complications.
Gilead now faces numerous lawsuits for drug toxicity but also unlawful marketing practices. If you or a loved one took Truvada or another TDF drug and experienced serious side effects, you may be entitled to legal compensation.
Truvada lawsuits claim Gilead manufactured a too toxic product and failed to adequately inform users of the serious risks of taking Truvada. We aim to hold Gilead responsible for their negligence in protecting you from too-toxic drugs. By partnering with our experienced Truvada injury lawyers, you may be able to not only seek justice for your suffering, but compensation to cover any financial burdens caused by your Truvada injuries.
Contact our Truvada injury lawyers today, hold Gilead responsible, and see if you qualify for financial compensation today.
